# The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease

> **NCT07680335** · NA · RECRUITING · sponsor: **Alzheimercentrum Amsterdam** · enrollment: 550 (estimated)

## Conditions studied

- Alzheimer Blood Biomarkers
- Alzheimer's Disease (AD)

## Interventions

- **DIAGNOSTIC_TEST:** Plasma p-tau217 and neurofilament light chain results

## Key facts

- **NCT ID:** NCT07680335
- **Lead sponsor:** Alzheimercentrum Amsterdam
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2026-07-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680335, "The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07680335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*